Pharmacokinetics and Metabolism of [14C] BMS-986278 in Healthy Male Participants
Latest Information Update: 06 Jun 2022
Price :
$35 *
At a glance
- Drugs BMS-986278 (Primary) ; Sincalide
- Indications Idiopathic pulmonary fibrosis; Interstitial lung diseases
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 24 Feb 2022 Status changed from not yet recruiting to completed.
- 01 Oct 2020 New trial record